{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-26-001887","form_type":"8-K","ticker":"AEMD","cik":"0000882291","company_name":"AETHLON MEDICAL INC","filed_at":"2026-03-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.903569+00:00","generated_at":"2026-05-15T11:16:45.297901+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Aethlon Medical discloses 1,569,110 shares outstanding after all pre-funded warrants exercised","bullets":["As of March 16, 2026, Aethlon Medical has 1,569,110 shares of common stock outstanding.","All previously outstanding pre-funded warrants have been exercised as of that date.","The share count update follows recent exercises of pre-funded warrants, per Item 8.01 filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-001887","json":"https://secwatch.observer/filing/0001683168-26-001887.json","markdown":"https://secwatch.observer/filing/0001683168-26-001887.md","text":"https://secwatch.observer/filing/0001683168-26-001887.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/882291/000168316826001887/0001683168-26-001887-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/882291/000168316826001887/aethlon_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T11:16:45.297901+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}